Gonadal function was assessed in 101 postpubertal subjects after chemotherapy for childhood Hodgkin's disease. All had received ChlVPP (chlorambucil, vinblastine, procarbazine, and prednisolone) chemotherapy alone, with no radiotherapy below the diaphragm. Go- nadotropin levels were available in 46
Gonadal function in pediatric patients following treatment for hodgkin disease
β Scribed by Green, Daniel M. ;Brecher, Martin L. ;Lindsay, Allan N. ;Yakar, Daniel ;Voorhess, Mary L. ;MacGillivray, Margaret H. ;Freeman, Arnold I.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 581 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Gonadal function was assessed by determination of the serum levels of follicleβstimulating hormone (FSH) and luteinizing hormone (LH) in 24 children and adolescents 6β98 months after completion of treatment for Hodgkin disease that included pelvic irradiation and/or combination chemotherapy. Four of the five women and six of the nine men who received pelvic irradiation had elevations of serum FSH. Nine of these patients with an elevated FSH received combination chemotherapy in addition to pelvic irradiation. Five of seven males who received combination chemotherapy but no pelvic irradiation and were postpubertal at the time of evaluation had an elevated FSH level. Three of these five were prepubertal at the time of treatment. These results suggest that gonadal dysfunction occurred frequently among children and adolescents following treatment that included combination chemotherapy for Hodgkin disease.
π SIMILAR VOLUMES
Background. Gonadal function in pediatric and young adult survivors of Hodgkin disease is not very well defined. This study evaluates the outcome following the Multiple Drug Protocol (MDP) and the results are compared to the published experience. Procedure. Ovarian and testicular function was assess
## Abstract Thyroid function was evaluated in a consecutively treated group of children and adolescents with Hodgkin disease who received incidental radiation to the thyroid gland. Ten of 27 (36.7%) were found to have elevated concentrations of thyroidβstimulating hormone (TSH). Two groups of pati